<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Biochemistry Quiz</title>
</head>
<body>
    <h1>Biochemistry Quiz</h1>
    <form id="quizForm">
        <ol>
            <li>
                <label>1. The major site of triacylglycerol synthesis is:</label><br>
                <input type="radio" name="q1" value="a"> a. Small intestine<br>
                <input type="radio" name="q1" value="b"> b. Adipose tissue<br>
                <input type="radio" name="q1" value="c"> c. Skeletal muscle<br>
                <input type="radio" name="q1" value="d"> d. Liver<br>
            </li>
            <li>
                <label>2. When oleic acid, 18:1(9), is desaturated at carbon 6 and then elongated, what is the correct representation of the product?</label><br>
                <input type="radio" name="q2" value="a"> a. 20:2 (8,11)<br>
                <input type="radio" name="q2" value="b"> b. 20:2 (6,9)<br>
                <input type="radio" name="q2" value="c"> c. 20:2 (7,9)<br>
                <input type="radio" name="q2" value="d"> d. 19:2 (7,9)<br>
            </li>
            <li>
                <label>3. Ketogenesis is a metabolic pathway unique to the ___</label><br>
                <input type="radio" name="q3" value="a"> a. Liver<br>
                <input type="radio" name="q3" value="b"> b. Muscle<br>
                <input type="radio" name="q3" value="c"> c. Kidney<br>
                <input type="radio" name="q3" value="d"> d. Brain<br>
            </li>
            <li>
                <label>4. The following are products of fatty acid ß-oxidation except:</label><br>
                <input type="radio" name="q4" value="a"> a. FADH2<br>
                <input type="radio" name="q4" value="b"> b. NADPH<br>
                <input type="radio" name="q4" value="c"> c. Acetyl CoA<br>
                <input type="radio" name="q4" value="d"> d. NADH<br>
            </li>
            <li>
                <label>5. Which of the following complexes of ETS does not account for the pumping out of protons from the mitochondrial matrix?</label><br>
                <input type="radio" name="q5" value="a"> a. Complex III<br>
                <input type="radio" name="q5" value="b"> b. Complex IV<br>
                <input type="radio" name="q5" value="c"> c. Complex I<br>
                <input type="radio" name="q5" value="d"> d. Complex II<br>
            </li>
            <li>
                <label>6. In the TCA cycle, which intermediate is regenerated at the end to start another cycle?</label><br>
                <input type="radio" name="q6" value="a"> a. Citrate<br>
                <input type="radio" name="q6" value="b"> b. Malate<br>
                <input type="radio" name="q6" value="c"> c. a-Ketoglutarate<br>
                <input type="radio" name="q6" value="d"> d. Oxaloacetate<br>
            </li>
            <li>
                <label>7. When oxygen is limited, which intermediate accumulates the most in the ETC?</label><br>
                <input type="radio" name="q7" value="a"> a. FADH2<br>
                <input type="radio" name="q7" value="b"> b. Cytochrome c oxidase<br>
                <input type="radio" name="q7" value="c"> c. Ubiquinone<br>
                <input type="radio" name="q7" value="d"> d. NADH<br>
            </li>
            <li>
                <label>8. Mitochondrial myopathy is characterized by weakness due to a defect in:</label><br>
                <input type="radio" name="q8" value="a"> a. Glycolysis<br>
                <input type="radio" name="q8" value="b"> b. Citric acid cycle<br>
                <input type="radio" name="q8" value="c"> c. Beta-oxidation<br>
                <input type="radio" name="q8" value="d"> d. Oxidative phosphorylation<br>
            </li>
            <li>
                <label>9. A volatile and biologically non-metabolized ketone body that can be detected in the breath of uncontrolled type I diabetes mellitus patients is:</label><br>
                <input type="radio" name="q9" value="a"> a. Acetyl CoA<br>
                <input type="radio" name="q9" value="b"> b. Acetone<br>
                <input type="radio" name="q9" value="c"> c. 3-Hydroxybutyrate<br>
                <input type="radio" name="q9" value="d"> d. Acetoacetate<br>
            </li>
            <li>
                <label>10. What is the role of ferrochelatase in heme metabolism?</label><br>
                <input type="radio" name="q10" value="a"> a. Converts heme to biliverdin<br>
                <input type="radio" name="q10" value="b"> b. Converts biliverdin to bilirubin<br>
                <input type="radio" name="q10" value="c"> c. Conjugates bilirubin in the liver<br>
                <input type="radio" name="q10" value="d"> d. Incorporates iron into protoporphyrin IX to form heme<br>
            </li>
            <li>
                <label>11. Which enzyme complex catalyzes the link reaction, and how does it achieve substrate channeling?</label><br>
                <input type="radio" name="q11" value="a"> a. Pyruvate dehydrogenase complex via tightly bound lipoamide group<br>
                <input type="radio" name="q11" value="b"> b. Citrate synthase by transferring intermediates between active sites<br>
                <input type="radio" name="q11" value="c"> c. Pyruvate decarboxylase through binding to coenzyme A<br>
                <input type="radio" name="q11" value="d"> d. Alpha-ketoglutarate dehydrogenase through direct coenzyme oxidation<br>
            </li>
            <li>
                <label>12. In the heme biosynthetic pathway, what is the regulatory effect of heme on ALA synthase?</label><br>
                <input type="radio" name="q12" value="a"> a. Inhibition<br>
                <input type="radio" name="q12" value="b"> b. Feedback on ferrochelatase<br>
                <input type="radio" name="q12" value="c"> c. No regulatory effect<br>
                <input type="radio" name="q12" value="d"> d. Activation<br>
            </li>
            <li>
                <label>13. Which glycolytic enzyme catalyzes a reaction requiring an inorganic phosphate (Pi) for its mechanism?</label><br>
                <input type="radio" name="q13" value="a"> a. Hexokinase<br>
                <input type="radio" name="q13" value="b"> b. Pyruvate kinase<br>
                <input type="radio" name="q13" value="c"> c. Enolase<br>
                <input type="radio" name="q13" value="d"> d. Glyceraldehyde-3-phosphate dehydrogenase<br>
            </li>
            <li>
                <label>14. During oxidative phosphorylation, what role does the proton motive force (PMF) play in the synthesis of ATP?</label><br>
                <input type="radio" name="q14" value="a"> a. Regulates enzyme activity<br>
                <input type="radio" name="q14" value="b"> b. Facilitates electron transport<br>
                <input type="radio" name="q14" value="c"> c. Drives ATP synthesis directly<br>
                <input type="radio" name="q14" value="d"> d. Generates heat<br>
            </li>
            <li>
                <label>15. Lack of the enzyme ___ in the liver makes it unable to use ketone bodies for fuel.</label><br>
                <input type="radio" name="q15" value="a"> a. Thiolase<br>
                <input type="radio" name="q15" value="b"> b. HMG CoA lyase<br>
                <input type="radio" name="q15" value="c"> c. HMG CoA synthase<br>
                <input type="radio" name="q15" value="d"> d. Thiophorase<br>
            </li>
            <li>
        <label>16. In the isomerization of glucose-6-phosphate to fructose-6-phosphate by phosphoglucose isomerase, which of the following changes occurs?</label><br>
        <input type="radio" name="q16" value="a"> a. Conversion of an aldose to a ketose<br>
        <input type="radio" name="q16" value="b"> b. Oxidation of the substrate<br>
        <input type="radio" name="q16" value="c"> c. Formation of a high-energy intermediate<br>
        <input type="radio" name="q16" value="d"> d. Loss of a phosphate group<br>
    </li>
    <li>
        <label>17. Which of the following is the first complex (Complex I) of ETS?</label><br>
        <input type="radio" name="q17" value="a"> a. NADH dehydrogenase<br>
        <input type="radio" name="q17" value="b"> b. ATP synthase<br>
        <input type="radio" name="q17" value="c"> c. Cytochrome aa3<br>
        <input type="radio" name="q17" value="d"> d. Cytochrome bc1<br>
    </li>
    <li>
        <label>18. The oxidation of isocitrate to a-ketoglutarate is accompanied by the production of:</label><br>
        <input type="radio" name="q18" value="a"> a. CO2<br>
        <input type="radio" name="q18" value="b"> b. FADH2<br>
        <input type="radio" name="q18" value="c"> c. GTP<br>
        <input type="radio" name="q18" value="d"> d. NADH<br>
    </li>
    <li>
        <label>19. Which condition is characterized by an inability of hepatocytes to excrete conjugated bilirubin into bile canaliculi, resulting in conjugated hyperbilirubinemia?</label><br>
        <input type="radio" name="q19" value="a"> a. Crigler-Najjar syndrome<br>
        <input type="radio" name="q19" value="b"> b. Gilbert’s syndrome<br>
        <input type="radio" name="q19" value="c"> c. Dubin-Johnson syndrome<br>
        <input type="radio" name="q19" value="d"> d. Hemolytic anemia<br>
    </li>
    <li>
        <label>20. Which intermediate in the TCA cycle undergoes a reaction that involves water removal followed by water addition?</label><br>
        <input type="radio" name="q20" value="a"> a. a-Ketoglutarate<br>
        <input type="radio" name="q20" value="b"> b. Fumarate<br>
        <input type="radio" name="q20" value="c"> c. Citrate<br>
        <input type="radio" name="q20" value="d"> d. Isocitrate<br>
    </li>
    <li>
        <label>21. Which of these inhibitors blocks electron flow from Complex III to cytochrome c by specifically targeting the Qo site of the complex?</label><br>
        <input type="radio" name="q21" value="a"> a. Antimycin A<br>
        <input type="radio" name="q21" value="b"> b. Cyanide<br>
        <input type="radio" name="q21" value="c"> c. Myxothiazol<br>
        <input type="radio" name="q21" value="d"> d. Rotenone<br>
    </li>
    <li>
        <label>22. Succinate dehydrogenase deficiency in paraganglioma leads to:</label><br>
        <input type="radio" name="q22" value="a"> a. Accumulated succinate<br>
        <input type="radio" name="q22" value="b"> b. Impaired ATP synthesis<br>
        <input type="radio" name="q22" value="c"> c. Elevated Acetyl-CoA<br>
        <input type="radio" name="q22" value="d"> d. Increased ROS production<br>
    </li>
    <li>
        <label>23. All of the following explain the biological role of bile salts except:</label><br>
        <input type="radio" name="q23" value="a"> a. They aid in the absorption of some Vitamins<br>
        <input type="radio" name="q23" value="b"> b. They aid in the digestion and absorption of proteins<br>
        <input type="radio" name="q23" value="c"> c. They provide a means of excreting cholesterol<br>
        <input type="radio" name="q23" value="d"> d. They assist in the digestion of lipids<br>
    </li>
    <li>
        <label>24. The primary products of lipid digestion in the jejunum are:</label><br>
        <input type="radio" name="q24" value="a"> a. Free fatty acids, Cholesteryl ester and 2-Monoacylglycerol<br>
        <input type="radio" name="q24" value="b"> b. Free fatty acids, free cholesterol and 2-Monoacylglycerol<br>
        <input type="radio" name="q24" value="c"> c. Free fatty acids, Cholesteryl ester and Triacylglycerol<br>
        <input type="radio" name="q24" value="d"> d. Free fatty acids, Free cholesterol and Triacylglycerol<br>
    </li>
    <li>
        <label>25. In heme biosynthesis, which step is most vulnerable to inhibition by lead?</label><br>
        <input type="radio" name="q25" value="a"> a. ALA synthase activity in the mitochondria<br>
        <input type="radio" name="q25" value="b"> b. ALA dehydratase activity in the cytoplasm<br>
        <input type="radio" name="q25" value="c"> c. Ferrochelatase activity in the mitochondria<br>
        <input type="radio" name="q25" value="d"> d. Protoporphyrinogen oxidase in the mitochondria<br>
    </li>
    <li>
        <label>26. Which metabolic process is upregulated in muscle cells during intense exercise to supply the Cori cycle with its substrate?</label><br>
        <input type="radio" name="q26" value="a"> a. Gluconeogenesis<br>
        <input type="radio" name="q26" value="b"> b. Anaerobic glycolysis<br>
        <input type="radio" name="q26" value="c"> c. Fatty acid oxidation<br>
        <input type="radio" name="q26" value="d"> d. Oxidative phosphorylation<br>
    </li>
    <li>
        <label>27. In a coupled reaction where the hydrolysis of ATP is coupled to an endergonic process, the standard free energy change (G°) is typically ___</label><br>
        <input type="radio" name="q27" value="a"> a. Zero<br>
        <input type="radio" name="q27" value="b"> b. Positive<br>
        <input type="radio" name="q27" value="c"> c. Indeterminate<br>
        <input type="radio" name="q27" value="d"> d. Negative<br>
    </li>
    <li>
        <label>28. In ETC, which complex directly interacts with molecular oxygen (O2)?</label><br>
        <input type="radio" name="q28" value="a"> a. Complex II<br>
        <input type="radio" name="q28" value="b"> b. Complex I<br>
        <input type="radio" name="q28" value="c"> c. Complex III<br>
        <input type="radio" name="q28" value="d"> d. Complex IV<br>
    </li>
    <li>
        <label>29. What is the immediate product of the condensation of two molecules of ALA in the heme biosynthetic pathway?</label><br>
        <input type="radio" name="q29" value="a"> a. Coproporphyrinogen III<br>
        <input type="radio" name="q29" value="b"> b. Porphobilinogen (PBG)<br>
        <input type="radio" name="q29" value="c"> c. Protoporphyrin IX<br>
        <input type="radio" name="q29" value="d"> d. Uroporphyrinogen III<br>
    </li>
    <li>
        <label>30. How many molecules of CO2 are released per Acetyl-CoA molecule oxidized in the TCA cycle?</label><br>
        <input type="radio" name="q30" value="a"> a. 2<br>
        <input type="radio" name="q30" value="b"> b. 1<br>
        <input type="radio" name="q30" value="c"> c. 3<br>
        <input type="radio" name="q30" value="d"> d. 4<br>
    </li>
    <li>
        <label>31. The following are possible episodes resulting from hypercholesterolemia except:</label><br>
        <input type="radio" name="q31" value="a"> a. Atherosclerosis<br>
        <input type="radio" name="q31" value="b"> b. Asthma<br>
        <input type="radio" name="q31" value="c"> c. Hypertension<br>
        <input type="radio" name="q31" value="d"> d. Heart attack<br>
    </li>
    <li>
        <label>32. Which of the following glycolytic reactions directly results in the production of NADH?</label><br>
        <input type="radio" name="q32" value="a"> a. Conversion of 3-phosphoglycerate to 2-phosphoglycerate<br>
        <input type="radio" name="q32" value="b"> b. Conversion of glucose-6-phosphate to fructose-6-phosphate<br>
        <input type="radio" name="q32" value="c"> c. Conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate<br>
        <input type="radio" name="q32" value="d"> d. Conversion of pyruvate to lactate<br>
    </li>
    <li>
        <label>33. ATP synthesis by ATP synthase is driven by the movement of:</label><br>
        <input type="radio" name="q33" value="a"> a. Protons<br>
        <input type="radio" name="q33" value="b"> b. Electrons<br>
        <input type="radio" name="q33" value="c"> c. NADH<br>
        <input type="radio" name="q33" value="d"> d. FADH2<br>
    </li>
    <li>
        <label>34. Which of the following enzymes catalyzes the rate limiting step in fatty acid synthesis?</label><br>
        <input type="radio" name="q34" value="a"> a. Fatty acid elongase<br>
        <input type="radio" name="q34" value="b"> b. Acetyl CoA carboxylase<br>
        <input type="radio" name="q34" value="c"> c. Fatty acid synthase<br>
        <input type="radio" name="q34" value="d"> d. Fatty acyl CoA desaturase<br>
    </li>
    <li>
        <label>35. Which of the following is the correct stoichiometry of ATP and GTP utilization in gluconeogenesis to form one molecule of glucose?</label><br>
        <input type="radio" name="q35" value="a"> a. 4 ATP and 1 GTP<br>
        <input type="radio" name="q35" value="b"> b. 4 ATP and 2 GTP<br>
        <input type="radio" name="q35" value="c"> c. 2 ATP and 1 GTP<br>
        <input type="radio" name="q35" value="d"> d. 6 ATP and 2 GTP<br>
    </li>
    <li>
        <label>36. The rate-limiting step in glycolysis is catalyzed by which of the following enzymes?</label><br>
        <input type="radio" name="q36" value="a"> a. Aldolase<br>
        <input type="radio" name="q36" value="b"> b. Pyruvate kinase<br>
        <input type="radio" name="q36" value="c"> c. Hexokinase<br>
        <input type="radio" name="q36" value="d"> d. Phosphofructokinase-1<br>
    </li>
    <li>
        <label>37. Which one of the following compounds is a common intermediate in ketogenesis and cholesterogenesis?</label><br>
        <input type="radio" name="q37" value="a"> a. Acetoacetic acid<br>
        <input type="radio" name="q37" value="b"> b. Malonyl-CoA<br>
        <input type="radio" name="q37" value="c"> c. Succinyl-CoA<br>
        <input type="radio" name="q37" value="d"> d. HMG-CoA<br>
    </li>
    <li>
        <label>38. The Gibbs free energy change (G) is an important parameter in determining the spontaneity of a reaction. A negative G indicates that the reaction is ___</label><br>
        <input type="radio" name="q38" value="a"> a. Equilibrium<br>
        <input type="radio" name="q38" value="b"> b. Exergonic<br>
        <input type="radio" name="q38" value="c"> c. Endergonic<br>
        <input type="radio" name="q38" value="d"> d. Isothermal<br>
    </li>
    <li>
        <label>39. Dietary cholesterol is transported by:</label><br>
        <input type="radio" name="q39" value="a"> a. HDL<br>
        <input type="radio" name="q39" value="b"> b. VLDL<br>
        <input type="radio" name="q39" value="c"> c. Chylomicrons<br>
        <input type="radio" name="q39" value="d"> d. LDL<br>
    </li>
    <li>
        <label>40. Which enzyme in the TCA cycle catalyzes a reaction that directly produces GTP (or ATP) through substrate-level phosphorylation?</label><br>
        <input type="radio" name="q40" value="a"> a. Aconitase<br>
        <input type="radio" name="q40" value="b"> b. Malate dehydrogenase<br>
        <input type="radio" name="q40" value="c"> c. Succinyl-CoA synthetase<br>
        <input type="radio" name="q40" value="d"> d. Succinate dehydrogenase<br>
    </li>
    <li>
        <label>41. What is the role of malate in the transport of oxaloacetate out of the mitochondria during gluconeogenesis?</label><br>
        <input type="radio" name="q41" value="a"> a. Malate inhibits glycolytic enzymes to favor gluconeogenesis<br>
        <input type="radio" name="q41" value="b"> b. Malate forms Acetyl-CoA, which then drives gluconeogenesis<br>
        <input type="radio" name="q41" value="c"> c. Malate acts as an intermediate to regenerate oxaloacetate in the cytosol<br>
        <input type="radio" name="q41" value="d"> d. Malate directly provides energy for oxaloacetate transport<br>
    </li>
    <li>
        <label>42. What is the primary function of the enzyme cytochrome c oxidase in the electron transport chain?</label><br>
        <input type="radio" name="q42" value="a"> a. Oxidation of ubiquinone (CoQ)<br>
        <input type="radio" name="q42" value="b"> b. Reduction of molecular oxygen (O2)<br>
        <input type="radio" name="q42" value="c"> c. Reduction of cytochrome c<br>
        <input type="radio" name="q42" value="d"> d. Oxidation of cytochrome c<br>
    </li>
    <li>
        <label>43. In hemolytic jaundice, what is the most likely reason for an increased level of unconjugated bilirubin in the blood?</label><br>
        <input type="radio" name="q43" value="a"> a. Excessive destruction of red blood cells<br>
        <input type="radio" name="q43" value="b"> b. Defective bilirubin transport into hepatocytes<br>
        <input type="radio" name="q43" value="c"> c. Obstruction of bile flow<br>
        <input type="radio" name="q43" value="d"> d. Reduced activity of UDP-glucuronosyltransferase<br>
    </li>
    <li>
        <label>44. Which coenzyme is directly required for the oxidative decarboxylation of pyruvate in the link reaction?</label><br>
        <input type="radio" name="q44" value="a"> a. Thiamine pyrophosphate (TPP)<br>
        <input type="radio" name="q44" value="b"> b. CoA-SH<br>
        <input type="radio" name="q44" value="c"> c. Coenzyme Q<br>
        <input type="radio" name="q44" value="d"> d. FAD<br>
    </li>
    <li>
        <label>45. An infant, born at 28 weeks’ gestation, rapidly gave evidence of respiratory distress. Clinical laboratory and imaging results supported the diagnosis of infant respiratory distress syndrome. Which of the following statements about this syndrome is true?</label><br>
        <input type="radio" name="q45" value="a"> a. The concentration of dipalmitoylphosphatidylcholine in the amniotic fluid would be expected to be lower than that of a full-term baby<br>
        <input type="radio" name="q45" value="b"> b. It is treated by administering surfactant to the mother just before she gives birth<br>
        <input type="radio" name="q45" value="c"> c. The lecithin/sphingomyelin ratio in the amniotic fluid is likely to be high (>2)<br>
        <input type="radio" name="q45" value="d"> d. It is a consequence of too few type II pneumocytes<br>
    </li>
    <li>
        <label>46. Which of the following is the precursor of heme in the heme biosynthetic pathway?</label><br>
        <input type="radio" name="q46" value="a"> a. Protoporphyrin IX<br>
        <input type="radio" name="q46" value="b"> b. Urobilinogen<br>
        <input type="radio" name="q46" value="c"> c. Heme oxygenase<br>
        <input type="radio" name="q46" value="d"> d. Biliverdin<br>
    </li>
    <li>
        <label>47. Which of the following is NOT a regulatory enzyme of the TCA cycle?</label><br>
        <input type="radio" name="q47" value="a"> a. Isocitrate dehydrogenase<br>
        <input type="radio" name="q47" value="b"> b. Succinyl-CoA synthetase<br>
        <input type="radio" name="q47" value="c"> c. a-Ketoglutarate dehydrogenase<br>
        <input type="radio" name="q47" value="d"> d. Citrate synthase<br>
    </li>
    <li>
        <label>48. Which of the following types of jaundice is most likely to present with conjugated hyperbilirubinemia?</label><br>
        <input type="radio" name="q48" value="a"> a. Obstructive jaundice<br>
        <input type="radio" name="q48" value="b"> b. Neonatal jaundice<br>
        <input type="radio" name="q48" value="c"> c. Hepatocellular jaundice<br>
        <input type="radio" name="q48" value="d"> d. Hemolytic jaundice<br>
    </li>
    <li>
        <label>49. Which of the following statements about gluconeogenesis is TRUE?</label><br>
        <input type="radio" name="q49" value="a"> a. It can utilize lactate, glycerol, and amino acids as substrates<br>
        <input type="radio" name="q49" value="b"> b. It occurs exclusively in the cytosol<br>
        <input type="radio" name="q49" value="c"> c. It produces a net gain of 2 ATP per glucose molecule synthesized<br>
        <input type="radio" name="q49" value="d"> d. It primarily occurs in muscle tissue<br>
    </li>
    <li>
        <label>50. The conversion of pyruvate to phosphoenolpyruvate in gluconeogenesis requires which of the following?</label><br>
        <input type="radio" name="q50" value="a"> a. ATP, GTP, and thiamine<br>
        <input type="radio" name="q50" value="b"> b. ATP, GTP, and biotin<br>
        <input type="radio" name="q50" value="c"> c. ATP and biotin only<br>
        <input type="radio" name="q50" value="d"> d. GTP and biotin only<br>
    </li><ol start="51">
    <li>
        <label>51. Which intermediate of heme metabolism accumulates in acute intermittent porphyria (AIP)?</label><br>
        <input type="radio" name="q51" value="a"> a. Porphobilinogen (PBG)<br>
        <input type="radio" name="q51" value="b"> b. Uroporphyrinogen III<br>
        <input type="radio" name="q51" value="c"> c. Coproporphyrinogen III<br>
        <input type="radio" name="q51" value="d"> d. Protoporphyrin IX<br>
    </li>
    <li>
        <label>52. An anti-obesity drug that inhibits gastric and pancreatic lipases, thereby decreasing fat absorption, resulting in weight loss is:</label><br>
        <input type="radio" name="q52" value="a"> a. Cortisol<br>
        <input type="radio" name="q52" value="b"> b. Asprin<br>
        <input type="radio" name="q52" value="c"> c. Metformin<br>
        <input type="radio" name="q52" value="d"> d. Orlistat<br>
    </li>
    <li>
        <label>53. During gluconeogenesis, the enzyme glucose-6-phosphatase is critical for:</label><br>
        <input type="radio" name="q53" value="a"> a. Bypassing the hexokinase step of glycolysis<br>
        <input type="radio" name="q53" value="b"> b. Generating free glucose from glucose-6-phosphate<br>
        <input type="radio" name="q53" value="c"> c. Adding a phosphate group to glucose<br>
        <input type="radio" name="q53" value="d"> d. Converting glucose-6-phosphate into glycogen<br>
    </li>
    <li>
        <label>54. A 4-month-old child is being evaluated for fasting hypoglycemia. Laboratory tests at admission reveal low levels of ketone bodies (hypoketonemia), free carnitine, and long-chain acylcarnitines in the blood. Free fatty acid levels in the blood were elevated. Deficiency of which of the following would best explain these findings?</label><br>
        <input type="radio" name="q54" value="a"> a. Carnitine palmitoyltransferase-I<br>
        <input type="radio" name="q54" value="b"> b. Long-chain fatty acid dehydrogenase<br>
        <input type="radio" name="q54" value="c"> c. Adipose triglyceride lipase<br>
        <input type="radio" name="q54" value="d"> d. Carnitine transporter<br>
    </li>
    <li>
        <label>55. According to the second law of thermodynamics, which statement best describes the entropy change in a closed biological system?</label><br>
        <input type="radio" name="q55" value="a"> a. Entropy is zero<br>
        <input type="radio" name="q55" value="b"> b. Entropy always decreases<br>
        <input type="radio" name="q55" value="c"> c. Entropy tends to increase<br>
        <input type="radio" name="q55" value="d"> d. Entropy remains constant<br>
    </li>
    <li>
        <label>56. Which of the following steps in glycolysis involves substrate-level phosphorylation?</label><br>
        <input type="radio" name="q56" value="a"> a. Aldolase reaction<br>
        <input type="radio" name="q56" value="b"> b. Phosphoglycerate kinase reaction<br>
        <input type="radio" name="q56" value="c"> c. Hexokinase reaction<br>
        <input type="radio" name="q56" value="d"> d. Glyceraldehyde-3-phosphate dehydrogenase reaction<br>
    </li>
    <li>
        <label>57. Which of the following are responsible for vasoconstriction and platelet aggregation?</label><br>
        <input type="radio" name="q57" value="a"> a. Leukotrienes<br>
        <input type="radio" name="q57" value="b"> b. Thromboxanes<br>
        <input type="radio" name="q57" value="c"> c. Prostacyclins<br>
        <input type="radio" name="q57" value="d"> d. Prostaglandins<br>
    </li>
    <li>
        <label>58. In the Cori cycle, lactate is transported to the liver via the bloodstream. What happens to lactate in the liver?</label><br>
        <input type="radio" name="q58" value="a"> a. It is oxidized to Acetyl-CoA and enters the TCA cycle<br>
        <input type="radio" name="q58" value="b"> b. It is oxidized to pyruvate and used for gluconeogenesis<br>
        <input type="radio" name="q58" value="c"> c. It is directly converted into glycogen<br>
        <input type="radio" name="q58" value="d"> d. It is reduced to pyruvate and converted into glucose<br>
    </li>
    <li>
        <label>59. Which one of the following lipoproteins is referred to as a good cholesterol?</label><br>
        <input type="radio" name="q59" value="a"> a. HDL<br>
        <input type="radio" name="q59" value="b"> b. LDL<br>
        <input type="radio" name="q59" value="c"> c. VLDL<br>
        <input type="radio" name="q59" value="d"> d. IDL<br>
    </li>
    <li>
        <label>60. The hallmark of non-steroidal anti-inflammatory drugs action is based on:</label><br>
        <input type="radio" name="q60" value="a"> a. Inhibition of cyclo-oxygenase II<br>
        <input type="radio" name="q60" value="b"> b. Phospholipase C<br>
        <input type="radio" name="q60" value="c"> c. Inhibition of phospholipase A2<br>
        <input type="radio" name="q60" value="d"> d. Inhibition of lipo-oxygenase<br>
    </li>
    </ol>
        <input type="button" value="Submit" onclick="calculateResults()">
    </form>
    
    <div id="result" style="display: none;">
        <h2>Your Results:</h2>
        <p id="score"></p>
    </div>

    <script>
    function calculateResults() {
        const answers = {
            q1: 'd', q2: 'a', q3: 'a', q4: 'b', q5: 'd', q6: 'd', q7: 'c', q8: 'd',
            q9: 'b', q10: 'd', q11: 'a', q12: 'a', q13: 'd', q14: 'c', q15: 'd', q16: 'a',
            q17: 'a', q18: 'a', q19: 'c', q20: 'c', q21: 'a', q22: 'a', q23: 'b', q24: 'b',
            q25: 'c', q26: 'b', q27: 'b', q28: 'd', q29: 'b', q30: 'a', q31: 'b', q32: 'c',
            q33: 'a', q34: 'b', q35: 'b', q36: 'd', q37: 'd', q38: 'b', q39: 'c', q40: 'c',
            q41: 'c', q42: 'b', q43: 'a', q44: 'a', q45: 'a', q46: 'a', q47: 'a', q48: 'a',
            q49: 'a', q50: 'b', q51: 'a', q52: 'd', q53: 'b', q54: 'd', q55: 'c', q56: 'b',
            q57: 'b', q58: 'b', q59: 'a', q60: 'a'
        };
        
        let score = 0;
        const form = document.forms['quizForm'];
        
        for (let i = 1; i <= 60; i++) { // Update this loop to check all 60 questions
            const questionName = `q${i}`;
            const selectedOption = form.querySelector(`input[name="${questionName}"]:checked`);
            
            if (selectedOption && selectedOption.value === answers[questionName]) {
                score++;
            }
        }
        
        const resultDiv = document.getElementById("result");
        resultDiv.style.display = 'block';
        document.getElementById("score").textContent = `You scored ${score} out of 60.`;
    }
</script>
    
<p><strong><em>PREPARED BY "A MAN FROM THE FUTURE"</em></strong></p>

    
